Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pathologic Complete Response × Observation × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pathologic Complete Response 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

thymoglobulin 1 relugolix 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 Whole-Body Irradiation 1 Tacrolimus 1 Surgical Procedures, Operative 1 Rituximab 1 Observation 1 Mycophenolic Acid 1 Melphalan 1 Clofarabine 1 Busulfan 1 Bone Marrow Transplantation 1 Blood Specimen Collection 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743555 2024-12-20

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡